Ainos Inc AIMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:47 PM EDT
2.46quote price arrow up+0.01 (+0.41%)
Volume
39,782
52 week range
1.25 - 18.00
Loading...
  • Open2.31
  • Day High2.48
  • Day Low2.21
  • Prev Close2.45
  • 52 Week High18.00
  • 52 Week High Date08/04/22
  • 52 Week Low1.25
  • 52 Week Low Date05/20/22

Key Stats

  • Market Cap47.92M
  • Shares Out19.48M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-80.87

KEY STATS

  • Open2.31
  • Day High2.48
  • Day Low2.21
  • Prev Close2.45
  • 52 Week High18.00
  • 52 Week High Date08/04/22
  • 52 Week Low1.25
  • 52 Week Low Date05/20/22
  • Market Cap47.92M
  • Shares Out19.48M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.92
  • YTD % Change-80.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.46
  • P/E (TTM)-5.36
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.26M
  • ROE (TTM)-160.32%
  • Revenue (TTM)680,000.00
  • Gross Margin (TTM)67.04%
  • Net Margin (TTM)-802.56%
  • Debt To Equity (MRQ)387.13%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ainos Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ainos, Inc. is engaged in developing biologics for the treatment of human and animal diseases. The Company is researching for the treatment of human disease indications, including Sjogren’s syndrome, thrombocytopenia, and other indications using interferon-alpha. The Company is also developing and manufacturing point-of-care testing rapid test kit products that include diagnostics for COVID-19, pneumonia, vaginal infection and helicobacter pylori bacterial infection. Its...
Chun-Hsien Tsai
Chairman of the Board, President, Chief Executive Officer
Hui-Lan Wu
Chief Financial Officer
Lawrence Lin
Executive Vice President - Operations
Address
8880 Rio San Diego Drive, Ste. 800
San Diego, CA
92108
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTH
Cyclo Therapeutics Inc
2.65-0.01-0.38%
NAVB
Navidea Biopharmaceuticals Inc
0.4499+0.003+0.67%
TRVN
Trevena Inc
0.2195-0.0116-5.0195%
TMBR
Timber Pharmaceuticals Inc
0.1179-0.0018-1.5038%
ACRX
AcelRx Pharmaceuticals Inc
0.3145-0.0105-3.2308%
EVOK
Evoke Pharma Inc
2.76-0.03-1.08%